Valerie DeBenedette

KAISER FOUNDATION HEALTH PLAN OF CO

10400 E ALAMEDA AVE

Valerie DeBenedette is managing editor of Drug Topics.

Articles

Cetuximab as an add-on to leucovorin, fluorouracil, and oxaliplatin for stage 3 colon cancer adds no benefit

August 01, 2012

A new study seems to indicate that adding cetuximab to the standard therapy for resected stage 3 colon cancer provides no additional benefits.